Analyst upgrades: GE, X, ABT, FNM, FRE and MITI
Posted Mar 20th 2008 10:52AM by Eric Buscemi
Filed under: Analyst Reports, Analyst Upgrades and Downgrades, General Electric (GE), Abbott Laboratories (ABT), Federal Natl Mtge (FNM), U.S. Steel (X)
.gif)
MOST NOTEWORTHY: Abbott Lab, Fannie Mae, Freddie Mac and Micromet were today's noteworthy upgrades:
- Wachovia upgraded Abbott Lab (NYSE: ABT) to Outperform from Market Perform as they believe their earlier concerns have been addressed. Past concerns included the potential for a negative outcome from the FDA panel on Xience and slowing prescription growth of lead drug Humira.
- Fannie Mae (NYSE: FNM) and Freddie Mac (NYSE: FRE) were raised to Outperform from Market Perform at Keefe Bruyette citing recent government actions to stabilize the mortgage markets.
- Micromet (NASDAQ: MITI) was upgraded at RBC Capital to Outperform from Sector Perform as they expect positive data for its lead candidate, MT103, by year-end.
OTHER UPGRADES:
Tags: abbott, abt, analyst, atheros, athr, fannie mae, FannieMae, fnm, fre, freddie mac, FreddieMac, ge, general electric, GeneralElectric, inthenews, micronet, miti, upgrade, us steel, UsSteel, x
Walmart's New Health Food Push: Is It Too Hard to Swallow?
Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
Goldman Earnings Sink After Buffett Dividend
Johnson & Johnson's Income Falls 23%
Burberry Shares Leap on Sales Update
